Protease-Activated Receptor-1 Antagonist F 16618 Reduces Arterial Restenosis by Down-Regulation of Tumor Necrosis Factor α and Matrix Metalloproteinase 7 Expression, Migration, and Proliferation of Vascular Smooth Muscle Cells - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Journal of Pharmacology and Experimental Therapeutics Année : 2011

Protease-Activated Receptor-1 Antagonist F 16618 Reduces Arterial Restenosis by Down-Regulation of Tumor Necrosis Factor α and Matrix Metalloproteinase 7 Expression, Migration, and Proliferation of Vascular Smooth Muscle Cells

Fichier non déposé

Dates et versions

hal-02592179 , version 1 (15-05-2020)

Identifiants

Citer

Pauline Chieng-Yane, Arnaud Bocquet, Robert Letienne, Thierry Bourbon, Sylvie Sablayrolles, et al.. Protease-Activated Receptor-1 Antagonist F 16618 Reduces Arterial Restenosis by Down-Regulation of Tumor Necrosis Factor α and Matrix Metalloproteinase 7 Expression, Migration, and Proliferation of Vascular Smooth Muscle Cells. Journal of Pharmacology and Experimental Therapeutics, 2011, 336 (3), pp.643-651. ⟨10.1124/jpet.110.175182⟩. ⟨hal-02592179⟩
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More